Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus

NCT00386594 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

10

Enrollment

INDIV

Sponsor class

Conditions

Barrett Esophagus

Interventions

DRUG: 852A

Sponsor

Rogers, B.H. Gerald, M.D.

Collaborators

[object Object]